What this record means
The record shows that “BOTOX REIMBURSEMENT SOLUTIONS” is an abandoned application – the USPTO marked it dead after the applicant failed to answer an Office action, with the abandonment notice dated July 12 2017; the owner listed is Allergan, Inc., a Delaware corporation. The filing covered a Class 044 service: providing reimbursement support for licensed health‑care professionals treating neurology, dermatology and urology patients, so a similar name used in any medical‑or‑beauty‑service context would be the closest area of concern. The record does not give Allergan control over every use of the words “BOTOX,” “reimbursement,” or “solutions” outside that specific service description. This was a Principal Register filing, not a Supplemental Register entry, and the prosecution history simply reflects the examiner’s amendment and the applicant’s failure to respond, leading to abandonment. The supplied history shows no oppositions, cancellations or other enforcement activity. I'd treat this as a meaningful concern if you plan a comparable service in the same medical fields.
Informational only - not legal advice.